Comparison between Aakaar Medical Technologies IPO and Monolithisch IPO.
Aakaar Medical Technologies IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Monolithisch IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Indorient Financial Services Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Alacrity Securities Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aakaar Medical Technologies IPO is up to ₹25.64 Cr whereas the issue size of the Monolithisch IPO is up to ₹77.91 Cr. The final issue price of Aakaar Medical Technologies IPO is ₹72.00 per share and of Monolithisch IPO is ₹143.00 per share.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹68.00 per share | ₹135.00 per share |
| Issue Price (Upper) | ₹72.00 per share | ₹143.00 per share |
| Issue Price (Final) | ₹72.00 per share | ₹143.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1600 shares | 1000 shares |
| Fresh Issue Size | 35,61,600 shares | 54,48,000 shares |
| Fresh Issue Size (Amount) | up to ₹25.64 Cr | up to ₹77.91 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,61,600 shares | 54,48,000 shares |
| Issue Size Total (Amount) | up to ₹25.64 Cr | up to ₹77.91 Cr |
Aakaar Medical Technologies IPO opens on Jun 20, 2025, while Monolithisch IPO opens on Jun 12, 2025. The closing date of Aakaar Medical Technologies IPO and Monolithisch IPO is Jun 24, 2025, and Jun 16, 2025, respectively.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |
|---|---|---|
| Anchor Bid Date | Jun 19, 2025 | Jun 11, 2025 |
| Issue Open | Jun 20, 2025 | Jun 12, 2025 |
| Issue Close | Jun 24, 2025 | Jun 16, 2025 |
| Basis Of Allotment (Tentative) | Jun 25, 2025 | Jun 17, 2025 |
| Initiation of Refunds (Tentative) | Jun 26, 2025 | Jun 18, 2025 |
| Credit of Share (Tentative) | Jun 26, 2025 | Jun 18, 2025 |
| Listing date (Tentative) | Jun 27, 2025 | Jun 19, 2025 |
| Anchor Lockin End date 1 | Jul 25, 2025 | Jul 16, 2025 |
| Anchor Lockin End date 2 | Sep 23, 2025 | Sep 14, 2025 |
Aakaar Medical Technologies IPO P/E ratio is 12.43, as compared to Monolithisch IPO P/E ratio of 15.79.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Aakaar Medical Technologies Limited Financial Information (Restated)Aakaar Medical Technologies Limited's revenue increased by 33% and profit after tax (PAT) rose by 110% between the financial year ending with March 31, 2025 and March 31, 2024.
| Monolithisch India Limited Financial Information (Restated Standalone)Monolithisch India Limited's revenue increased by 41% and profit after tax (PAT) rose by 70% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.11 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.01 | 73.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.43 | 15.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹102.04 Cr. | ₹310.82 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 53.94% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.02% | 46.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.98 | 0.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.79 | ₹9.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 33.81% | 41.15% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aakaar Medical Technologies IPO Retail Individual Investors (RII) are offered 12,48,000 shares while in Monolithisch IPO retail investors are offered 12,48,000 shares. Qualified Institutional Buyers (QIB) are offered 7,12,000 shares in Aakaar Medical Technologies IPO and 10,90,000 shares in Monolithisch IPO.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |
|---|---|---|
| Anchor Investor Reserveration | 10,67,200 shares | 16,33,000 shares |
| Market Maker Reserveration | 1,88,800 shares | 2,88,000 shares |
| QIB | 7,12,000 shares | 10,90,000 shares |
| NII | 5,34,400 shares | 8,18,000 shares |
| RII | 12,48,000 shares | 19,07,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,61,600 shares | 54,48,000 shares |
Aakaar Medical Technologies IPO subscribed 2.28x in total, whereas Monolithisch IPO subscribed 182.89x.
| Aakaar Medical Technologies IPO | Monolithisch IPO | |
|---|---|---|
| QIB (times) | 3.51x | 129.20x |
| NII (times) | 1.48x | 459.99x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.93x | 94.71x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.28x | 182.89x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
